Bharat Biotech

Bharat Biotech's Covaxin Granted Approval "Sans Due Process": Congress' Manish Tewari

India News | Press Trust of India | Saturday January 16, 2021

Senior Congress leader Manish Tewari today raised questions over the emergency use approval granted to the indigenously developed Covaxin and alleged that it was "sans due process". His remarks come on a day India launched one of the world's biggest vaccination drives against the deadly coronavirus.

'Together, We Can Win': Twitter Chatter Upbeat As India Gets Vaccinated

India News | Edited by Sumana Nandy | Saturday January 16, 2021

Social media chatter has been picking up steadily since morning today when India's massive vaccination programme against COVID-19 started with a sanitation worker getting the first shot of the two-dose vaccine. The country is prioritising nurses, doctors and other frontline medical staff since they run the highest risk of getting infected.

"Will Prefer Covishield Over Covaxin": Delhi Hospital Doctors Concerned

India News | Reported by Saurabh Shukla and Sukirti Dwivedi, edited by Harish Pullanoor | Sunday January 17, 2021

Resident doctors at one of Delhi's biggest healthcare hubs, the Ram Manohar Lohia Hospital, on Saturday demanded they be administered Covishield vaccine and not Covaxin since the former has completed all three stages of trials as required under protocol. The second one, produced by Hyderabad-based Bharat Biotech, is still only undergoing stage-III ...

"In Case Of Adverse Events...": What Covaxin Consent Form Says

India News | Reported By Sukirti Dwivedi, Edited By Deepshikha Ghosh | Saturday January 16, 2021

As India's vaccination drive began today with Covid shots to health workers, those receiving Bharat Biotech's Covaxin were asked to sign consent forms that assured compensation if any adverse effect was found linked to the vaccine.

Coronavirus Vaccines Explained: How The Two Shots Launching In India Work

India News | Reported by Sukirti Dwivedi, Edited by Divyanshu Dutta Roy | Saturday January 16, 2021

India on Saturday will launch one of the world's biggest vaccination programmes with vaccines manufactured in the country - one developed by Oxford University and AstraZeneca, the other by Bharat Biotech International with a state-run institute.

"Beginning Of End Of Covid": India Starts Vaccinations Today - 10 Points

India News | Reported by Sukirti Dwivedi, Edited by Divyanshu Dutta Roy | Saturday January 16, 2021

The nationwide COVID-19 vaccination drive will be launched by Prime Minister Narendra Modi at 10:30 am today, setting off India on the path towards overcoming the pandemic that has upended lives, ravaged the economy and unleashed unprecedented suffering over the last 12 months. One of the world's biggest vaccination programmes aimed at inoculating ...

Coronavirus Vaccination: Centre To Compare Covaxin, Covishield Vaccines On Different Parameters

India News | ANI | Friday January 15, 2021

The Ministry of Health and Family Welfare (MoHFW) said on Thursday that the government will compare the coronavirus vaccines - Covishield and Covaxin on different parameters for the purposes of recordkeeping.

Vaccine Questions Answered As India Set For First Covid Shots

India News | Reported by Sukirti Dwivedi, Edited by Arun Nair | Saturday January 16, 2021

Ahead of the launch of Covid vaccination on Saturday, the Centre has circulated a factsheet with information on the two vaccines -- Covishield and Covaxin -- that will be used in what officials describe as the 'world's biggest' such exercise. Around 30 crore people will be vaccinated in the next few months during the nationwide drive.

Covid Vaccine Roll Out At 81 Sites In Delhi, Covaxin At 6 Hospitals

India News | Reported by Sukirti Dwivedi, Edited by Anindita Sanyal | Thursday January 14, 2021

Delhi will have 81 sites where Covid vaccine will be administered. Of these the Covishield vaccine -- developed by the Oxford University -- will be given at 75 sites that would include government and private hospitals. Bharat Biotech's Covaxin will be given at six sites -- all of which are hospitals run by the Central government.

Assam First To Get Both Covid Vaccines, Storage Ready For 3 Crore Doses

India News | Written by Ratnadip Choudhury | Wednesday January 13, 2021

Assam became the first state in the northeast to have received both the coronavirus vaccines -- Covishield and Covaxin -- ahead of the mass inoculation programme set to start January 16.

Brazilian Clinics To Buy Bharat Biotech's Covid Vaccine Pending Approval

India News | Reuters | Wednesday January 13, 2021

Brazil's private sector vaccine clinics will be able to give customers a COVID-19 shot developed by Bharat Biotech once Brazil's federal health regulator has approved the drug, the head of the Brazilian Association of Vaccine Clinics (ABCVAC) said on Wednesday.

"Indians Aren't Guinea Pigs": Congress MP Questions Covaxin Rollout

India News | Edited by Harish Pullanoor | Wednesday January 13, 2021

The controversy around Covaxin, one of the two anti-COVID-19 vaccines India will deploy to fight back the pandemic, refuses to die even as the Indian government goes full-steam ahead with the mass inoculation programme. As Bharat Biotech's product was carried to Delhi and 10 other cities this morning, the Congress party sounded another note of caut...

Day After Serum Institute, Bharat Biotech Rolls Out Homegrown Vaccine

India News | Reported by Uma Sudhir, Edited by Arun Nair | Wednesday January 13, 2021

The first batches of Covaxin, the Bharat Biotech's coronavirus vaccine, left Hyderabad early this morning for Delhi and 10 other cities, a day after Serum Institute of India rolled out its vaccine against COVID-19 ahead of the nationwide inoculation drive which officials say will be the 'world's biggest'.

Ahead Of Covid Vaccine Rollout, PM Modi Meeting Chief Ministers

India News | Edited by Anindita Sanyal | Monday January 11, 2021

Prime Minister Narendra Modi is holding an online meeting with Chief Ministers of all states to discuss the COVID-19 situation and the rollout of vaccines that has been scheduled for January 16. Two vaccines -- Serum Institute of India's Covishield and Bharat Biotech's Covaxin -- have been approved by the country's drugs regulator for rollout acros...

Bhopal Vaccine Volunteer Death Unrelated To Dose: Bharat Biotech

India News | Written by Anurag Dwary | Saturday January 9, 2021

The death of a 45-year-old man in Madhya Pradesh's Bhopal - a volunteer for Phase III trials for Covaxin - was due to "other reasons" and not a severe adverse effect, Dr Anil Dixit, the Dean of the city's People's Medical College, said on Friday